Search

everythinglearnresearchcommunity

for

Search:↓

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Hypothyroidism in dogs is usually caused by immune system issues or gland atrophy, affects middle-aged purebreds most, and is treatable with medication.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Thyroid hormone receptors are essential for hair growth and wound healing.

High levels of cortisol in hair show long-term stress which can lower fertility in animals.

Melatonin may help reduce the needed dose of prednisolone and improve hair growth in alopecia areata patients.

A brain-made hormone can protect against memory-related brain damage caused by harmful proteins.

The document concludes that the hCG protocol may help in obesity treatment and could be scientifically justified, but more research is needed.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

More research is needed to understand how testosterone is maintained in adult males.

Diagnosing PCOS in teenagers is hard because its symptoms often look like normal puberty, and there's a need for better diagnosis methods and agreement on criteria.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Injecting alpha-melanocyte-stimulating hormone in mice improved skin healing and reduced scarring.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

A boy with GAPO syndrome had hair loss similar to male pattern baldness without hormone issues, possibly due to skin or blood vessel problems.

Environmental factors and chemicals might affect hormone balance and contribute to common hair loss.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.